1. All‐trans retinoic acid and arsenic combination therapy benefits low‐to‐intermediate‐risk patients with newly diagnosed acute promyelocytic leukaemia: a long‐term follow‐up based on multivariate analysis. (30th March 2015) Authors: Zhu, Hongming; Hu, Jiong; Li, Xiaoyang; Chen, Li; Zhao, Huijin; Zhou, Wei; Wang, Lining; Zhao, Xia; Zhang, Yunxiang; Chen, Yu; Sun, Huiping; Chen, Qiusheng; Chen, Yu; Zhao, Weili; Mi, Jianqing; Shen, Zhixiang; Chen, Zhu; Wang, Zhenyi; Li, Junmin; Chen, Saijuan Journal: British journal of haematology Issue: Volume 171:Number 2(2015:Oct.) Page Start: 277 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Optimization of idarubicin and cytarabine induction regimen with homoharringtonine for newly diagnosed acute myeloid leukemia patients based on the peripheral blast clearance rate: A single‐arm, phase 2 trial (RJ‐AML 2014). Issue 1 (1st November 2021) Authors: Zhang, Yunxiang; Li, Xiaoyang; Weng, Xiangqin; Shen, Yang; Chen, Yu; Zheng, Yu; Zhao, Huijin; You, Jianhua; Mao, Yuanfei; Wang, Lining; Wu, Min; Sheng, Yan; Wu, Jing; Hu, Jiong; Chen, Qiusheng; Li, Junmin Journal: American journal of hematology Issue: Volume 97:Issue 1(2022) Page Start: 43 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗